Global Blood Coagulation Testing Market To Exceed USD 8.17 Billion By 2035 | CAGR Of 6.1%

Global Blood Coagulation Testing Market To Exceed USD 8.17 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global Blood Coagulation Testing Market Size is Expected To Grow from USD 4.26 Billion in 2024 to USD 8.17 Billion by 2035, at a CAGR of 6.1% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the " Global Blood Coagulation Testing Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Consumables and Instruments), By Application (Prothrombin Time, Activated Partial Thromboplastin, Thrombin Time, and Activated Clotting Time), By End-Use (Hospitals, Clinical, Laboratories, Point-of-Care Testing, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/blood-coagulation-testing-market     

The Blood Coagulation Testing Market Size involves diagnostic tools and technologies designed to assess blood clotting functions. These tests are vital for diagnosing and managing conditions like hemophilia, deep vein thrombosis, liver dysfunction, and bleeding risks during surgeries. Key parameters measured include prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen. Market growth is fueled by the rising incidence of cardiovascular and thrombotic disorders, increased surgical procedures, and a growing elderly population prone to clotting issues. Rising health consciousness, frequent use of anticoagulants, and the need for ongoing monitoring further elevate testing demand. Technological advancements such as point-of-care systems, lab-on-a-chip platforms, and automated analyzers enhance diagnostic speed and accuracy. Emerging markets with expanding healthcare infrastructure, along with innovations in AI and machine learning, offer new opportunities. Additionally, the shift toward self-monitoring and home-based testing supports long-term management and the advancement of personalized healthcare. Blood coagulation testing faces limits from high costs, limited access, regulations, staffing, and accuracy issues.

The consumables segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the blood coagulation testing market is divided into consumables and instruments. Among these, the consumables segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Consumables play a vital role in supporting diagnostic equipment functionality and uninterrupted testing, especially in high-throughput labs. Advances like longer shelf life and improved stability drive growth, aligning with healthcare’s focus on efficiency and affordability.

The prothrombin time segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the application, the blood coagulation testing market is divided into prothrombin time, activated partial thromboplastin, thrombin time, and activated clotting time. Among these, the prothrombin time segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The broad adoption of PT tests in healthcare settings stems from their effectiveness in evaluating blood clotting, supporting the diagnosis and treatment of disorders like liver dysfunction and vitamin K deficiency through essential coagulation insights.

The hospitals segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the blood coagulation testing market is divided into hospitals, clinical, laboratories, point-of-care testing, and others. Among these, the hospitals segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The adoption of advanced diagnostic tools in hospitals enables fast, accurate testing crucial for managing acute and chronic illnesses. As hospitals expand into full-service care hubs, demand for high-end coagulation testing continues to grow.

North America is expected to hold the majority share of the global blood coagulation testing market during the forecast period.

North America is expected to hold the majority share of the global blood coagulation testing market during the forecast period. The region leads due to its strong healthcare framework, widespread use of advanced diagnostics, and ongoing investment in research. Major industry players and ample funding for innovation also drive growth. The U.S. excels with extensive hospital networks using routine coagulation testing.

Asia Pacific is anticipated to grow at the fastest pace in the global blood coagulation testing market during the forecast period. This growth is driven by a rising population, greater health awareness, and government efforts to improve healthcare access and quality. Rapid healthcare development in China and India, along with increasing chronic diseases and demand for affordable care, fuels the Asia Pacific’s market expansion.

Major vendors in the global blood coagulation testing market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Micropoint Biosciences, Danaher Corporation, Medtronic, Helena Laboratories, Werfen, HORIBA, Ltd., Nihon Kohden Corporation, and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In July 2025, Siemens Healthineers launched the CN-3000 and CN-6000 Hemostasis Systems in Canada after Health Canada approval. These systems offer a broad range of routine and specialty coagulation assays, helping laboratories identify clotting abnormalities and providing comprehensive solutions for diagnosing bleeding and thrombotic disorders.

• In May 2025, Danaher announced a partnership with AstraZeneca to develop and commercialize innovative diagnostic tools aimed at helping clinicians identify patients who would benefit most from precision medicine treatments, advancing personalized healthcare solutions.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the blood coagulation testing market based on the below-mentioned segments:

Global Blood Coagulation Testing Market, By Product Type

• Consumables
• Instruments

Global Blood Coagulation Testing Market, By Application

• Prothrombin Time
• Activated Partial Thromboplastin
• Thrombin Time
• Activated Clotting Time

Global Blood Coagulation Testing Market, By End-Use

• Hospitals
• Clinical
• Laboratories
• Point-of-Care Testing
• Others

 Global Blood Coagulation Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter